Indivisible Partners
IMNM icon

Indivisible Partners’s Immunome IMNM Stock Holding History

Indivisible Partners’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$270K Buy
+12,569
New +$312K 0.01% 605

Other funds holding IMNM

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Mitsubishi UFJ Asset Management (UK)
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $213M AUM 36.38% 1-Year Est. Return
Magnus Financial Group
Magnus Financial Group New York $1.5B AUM 16.47% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Maltin Wealth Management
Maltin Wealth Management Ridgewood, New Jersey $308M AUM 16.5% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Indivisible Partners's IMNM Position: Q3 2026 in Review

Indivisible Partners opened a new position in Immunome (IMNM) in Q3 2026: 12,569 shares worth $270K. The stake represents 0.01% of the portfolio and ranks #605 among its holdings.

19 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • Indivisible Partners held 12,569 shares of Immunome worth $270K as of Q3 2026.
  • Immunome was a new Indivisible Partners position in Q3 2026.
  • Immunome made up 0.01% of Indivisible Partners's portfolio in Q3 2026, its #605 holding.
  • 19 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Indivisible Partners's 13F filing for Q3 2026, filed 26 Oct 2026.